Benjamin F. Edwards & Company’s Hologic HOLX Stock Holding History

Benjamin F. Edwards & Company’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$88K	Buy	1,190 +110	+10%	+$8.25K	﹤0.01%	1143
2024 Q1	$84K	Sell	1,080 -110	-9%	-$8.18K	﹤0.01%	1147
2023 Q4	$85K	Hold	1,190	–	–	﹤0.01%	1118
2023 Q3	$83K	Hold	1,190	–	–	﹤0.01%	932
2023 Q2	$96K	Hold	1,190	–	–	﹤0.01%	916
2023 Q1	$96K	Hold	1,190	–	–	﹤0.01%	922
2022 Q4	$89K	Hold	1,190	–	–	﹤0.01%	936
2022 Q3	$77K	Hold	1,190	–	–	﹤0.01%	941
2022 Q2	$82K	Buy	1,190 +1,000	+526%	+$74.2K	﹤0.01%	923
2022 Q1	$15K	Hold	190	–	–	﹤0.01%	1284
2021 Q4	$15K	Hold	190	–	–	﹤0.01%	1298
2021 Q3	$14K	Hold	190	–	–	﹤0.01%	1311
2021 Q2	$13K	Buy	+190	New	+$12.7K	﹤0.01%	1315
2018 Q2	–	Sell	-100	Closed	-$4K	–	1623
2018 Q1	$4K	Buy	+100	New	+$4.04K	﹤0.01%	1444

Other funds holding HOLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Benjamin F. Edwards & Company's HOLX Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its Hologic (HOLX) stake by 10% in Q2 2024, buying an estimated $8.25K and bringing the position to 1,190 shares worth $88K. The position accounts for ﹤0.01% of the portfolio, ranked #1143.

Benjamin F. Edwards & Company first reported a position in HOLX in Q1 2018 and has held it in 14 quarters since. The position peaked at $96K in Q2 2023. 703 funds tracked by Wall St. Rank hold HOLX as of Q2 2024.

Benjamin F. Edwards & Company held 1,190 shares of Hologic worth $88K as of Q2 2024.
Benjamin F. Edwards & Company bought 110 Hologic shares in Q2 2024, an estimated $8.25K.
Hologic made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1143 holding.
Benjamin F. Edwards & Company first reported a position in Hologic in Q1 2018 and has held it in 14 quarters since.
Benjamin F. Edwards & Company's Hologic position peaked at $96K in Q2 2023.
703 funds tracked by Wall St. Rank held Hologic as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.